Na Yong Sub, Kim Jin Hyoung, Baek Moon Seong, Kim Won-Young, Baek Ae-Rin, Lee Bo Young, Seong Gil Myeong, Lee Song-I
Department of Pulmonology and Critical Care Medicine, Chosun University Hospital, Gwangju, Korea.
Division of Respiratory and Critical Care Medicine, Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.
Acute Crit Care. 2022 Aug;37(3):303-311. doi: 10.4266/acc.2022.00017. Epub 2022 Jul 5.
Elderly patients with coronavirus disease 2019 (COVID-19) have a high disease severity and mortality. However, the use of the frailty scale and severity score to predict in-hospital mortality in the elderly is not well established. Therefore, in this study, we investigated the use of these scores in COVID-19 cases in the elderly.
This multicenter retrospective study included severe COVID-19 patients admitted to seven hospitals in Republic of Korea from February 2020 to February 2021. We evaluated patients' Acute Physiology and Chronic Health Evaluation (APACHE) II score; confusion, urea nitrogen, respiratory rate, blood pressure, 65 years of age and older (CURB-65) score; modified early warning score (MEWS); Sequential Organ Failure Assessment (SOFA) score; clinical frailty scale (CFS) score; and Charlson comorbidity index (CCI). We evaluated the predictive value using receiver operating characteristic (ROC) curve analysis.
The study included 318 elderly patients with severe COVID-19 of whom 237 (74.5%) were survivors and 81 (25.5%) were non-survivors. The non-survivor group was older and had more comorbidities than the survivor group. The CFS, CCI, APACHE II, SOFA, CURB-65, and MEWS scores were higher in the non-survivor group than in the survivor group. When analyzed using the ROC curve, SOFA score showed the best performance in predicting the prognosis of elderly patients (area under the curve=0.766, P<0.001). CFS and SOFA scores were associated with in-hospital mortality in the multivariate analysis.
The SOFA score is an efficient tool for assessing in-hospital mortality in elderly patients with severe COVID-19.
2019年冠状病毒病(COVID-19)老年患者疾病严重程度高且死亡率高。然而,使用衰弱量表和严重程度评分来预测老年患者的院内死亡率尚未得到充分证实。因此,在本研究中,我们调查了这些评分在老年COVID-19病例中的应用。
这项多中心回顾性研究纳入了2020年2月至2021年2月在韩国七家医院住院的重症COVID-19患者。我们评估了患者的急性生理与慢性健康状况评估(APACHE)II评分;意识模糊、尿素氮、呼吸频率、血压、年龄≥65岁(CURB-65)评分;改良早期预警评分(MEWS);序贯器官衰竭评估(SOFA)评分;临床衰弱量表(CFS)评分;以及Charlson合并症指数(CCI)。我们使用受试者工作特征(ROC)曲线分析评估预测价值。
该研究纳入了318例老年重症COVID-19患者,其中237例(74.5%)存活,81例(25.5%)未存活。未存活组比存活组年龄更大且合并症更多。未存活组的CFS、CCI、APACHE II、SOFA、CURB-65和MEWS评分高于存活组。使用ROC曲线分析时,SOFA评分在预测老年患者预后方面表现最佳(曲线下面积=0.766,P<0.001)。多因素分析中,CFS和SOFA评分与院内死亡率相关。
SOFA评分是评估老年重症COVID-19患者院内死亡率的有效工具。